Clinical Trial Update: Brimonidine Eye Drops in the Prevention of Myopia Progression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating brimonidine eye drops for preventing progression of myopia; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Brimonidine eye drops (brimonidine tartrate)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: Myopia | Phase 2 | Status: NOT_YET_RECRUITING